Literature DB >> 489551

Regulation of cholesterol synthesis in primary rat hepatocyte culture cells. Possible regulatory site at sterol demethylation.

C Havel, E Hansbury, T J Scallen, J A Watson.   

Abstract

Primary rat hepatocyte culture cells were used to study the acute regulation of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase activity in response to 25-hydroxycholesterol, 3 beta,5 alpha,6 beta-cholestantriol, and mevalonolactone. All three effectors caused a rapid suppression of HMG-CoA reductase activity. 25-Hydroxycholesterol also caused an increase in the ratio of newly synthesized methyl sterols to newly synthesized C27-sterols. Furthermore, in 25-hydroxycholesterol-treated cells, the relative contribution of delta 24-sterol precursors to the nonsaponifiable lipid fraction increased. Di- and trimethyl-diene sterols were the dominant methyl sterols synthesized in the presence of 25-hydroxycholesterol. 3 beta,5 alpha,6 beta-Cholestrantriol (50 microM) also caused a very strong (97%) suppression of sterol demethylation; 4,4-dimethylmonoene sterols were more prominent (23%) in cells treated with 3 beta,5 alpha,6 beta-cholestrantriol, than in cells treated with 25-hydroxycholesterol (2%). The rates of both unesterified and esterified sterol synthesis increased as a function of exogenous mevalonolactone concentration. C27-sterol synthesis was saturated at a concentration of (R)-mevalonolactone which produced only a 33% suppression of HMG-CoA reductase activity. However, there was a direct relationship between the accumulation of methyl sterols and the decrease in HMG-CoA reductase activity. With the aid of triparanol, it was demonstrated that the suppression of HMG-CoA reductase activity by mevalonolactone was linked with the ability of the cells to convert squalene-2,3-epoxide into sterols. The results described in the present article support an important and perhaps necessary relationship between the rate of methyl sterol conversion of C27-sterols and the suppression or inhibition of HMG-Coa reductase in primary hepatocyte culture cells.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 489551

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

Review 1.  Use of hepatocytes in primary culture for biochemical studies on liver functions.

Authors:  A Ichihara; T Nakamura; K Tanaka
Journal:  Mol Cell Biochem       Date:  1982-04-02       Impact factor: 3.396

2.  Evidence for phosphorylation/dephosphorylation of rat liver acyl-CoA:cholesterol acyltransferase.

Authors:  K L Gavey; D L Trujillo; T J Scallen
Journal:  Proc Natl Acad Sci U S A       Date:  1983-04       Impact factor: 11.205

3.  Regulation of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in human hepatoma cell line Hep G2. Effects of inhibitors of cholesterol synthesis on enzyme activity.

Authors:  A Boogaard; M Griffioen; L H Cohen
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

4.  The effect of (-)-hydroxycitrate on the activity of the low-density-lipoprotein receptor and 3-hydroxy-3-methylglutaryl-CoA reductase levels in the human hepatoma cell line Hep G2.

Authors:  T A Berkhout; L M Havekes; N J Pearce; P H Groot
Journal:  Biochem J       Date:  1990-11-15       Impact factor: 3.857

5.  Overproduction of a Mr 92,000 protomer of 3-hydroxy-3-methylglutaryl-coenzyme A reductase in compactin-resistant C100 cells.

Authors:  E C Hardeman; H S Jenke; R D Simoni
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

6.  A possible regulatory role of squalene epoxidase in Chinese hamster ovary cells.

Authors:  H Eilenberg; I Shechter
Journal:  Lipids       Date:  1984-07       Impact factor: 1.880

7.  Multiple inhibitory effects of garlic extracts on cholesterol biosynthesis in hepatocytes.

Authors:  R Gebhardt
Journal:  Lipids       Date:  1993-07       Impact factor: 1.880

8.  Dolichol biosynthesis in human malignant cells.

Authors:  A Henry; P W Stacpoole; C M Allen
Journal:  Biochem J       Date:  1991-09-15       Impact factor: 3.857

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.